FDA permits Oramed Pharma to test oral insulin drug

05/19/2013 | RTT News

The FDA approved Oramed Pharmaceuticals' investigational new drug application for ORMD-0801, an oral insulin capsule for patients with diabetes. The company plans to begin a Phase II clinical trial of the drug for type 2 diabetes in the U.S.

View Full Article in:

RTT News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ